BSX

NYSE Healthcare

Boston Scientific Corporation Common Stock

Medical Devices

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

๐Ÿ“Š Market Data
Price$56.50
Volume12,109,298
Market Cap83.97B
Beta0.780
RSI (14-Day)36.3
200-Day MA$90.00
50-Day MA$66.94
52-Week High$109.50
52-Week Low$56.05
P/E Ratio23.64
Forward P/E15.01
Price / Book3.46
๐ŸŽฏ Investment Strategy Scores

BSX scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 40/100โ–ฒ +1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 65/100โ–ฒ +5
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 97/100โ€” 0
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 11/100โ–ผ -3
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ”ช Falling Knife (97/100) โ€” this strategy Contrarian plays (oversold + below moving average).

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (11/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find BSX in your text

Paste any article, transcript, or post โ€” the tool will extract BSX and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.